Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-Hodgkin lymphoma

Valera‚ Elvis Terci; Queiroz‚ Rosane Gomes; Brassesco‚ María Sol; Scrideli‚ Carlos Alberto; Neves‚ Fábia; Tone‚ Luiz Gonzaga

Advanced search

Search - Use quotation marks to get a more specific result

Index

Field of knowledge

Start date

Betweenand

(Reference retrieved automatically from Google Scholar through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-Hodgkin lymphoma

Full text
Author(s):	Valera‚ Elvis Terci ; Queiroz‚ Rosane Gomes ; Brassesco‚ María Sol ; Scrideli‚ Carlos Alberto ; Neves‚ Fábia ; Tone‚ Luiz Gonzaga Total Authors: 6
Document type:	Journal article
Source:	PEDIATRIC BLOOD & CANCER; v. 57, n. 2, p. 348-349, 2011.

FAPESP's process:	10/16652-9 - NF-kB inhibition in glioblastoma: in vitro and in vivo effects of DHMEQ in tumor chemoresistance, invasion and progression
Grantee:	María Sol Brassesco Annichini
Support Opportunities:	Scholarships in Brazil - Young Researchers

Short URL

Compartilhe esta página